ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Wren Laboratories Announces Discontinuation of NETest 1.0 in Favor of Advanced NETest 2.0
March 03, 2025Wren Laboratories discontinues NETest 1.0, replacing it with NETest 2.0. An AI-enhanced liquid biopsy, it offers high accuracy and sets a new non-invasive monitoring standard. -
Novel radionuclide therapy found to be more effective in NET patients
March 24, 2021The study shows modifying the standard of care for late-stage neuroendocrine tumours (NETs) with Evans blue dye makes the treatment more effective and potentially less toxic. -
Cartesian Initiates Trial of Cell Therapy for ARDS, COVID-19
September 02, 2020Cartesian Therapeutics has initiated a Phase 1/2 clinical trial of its lead RNA-engineered mesenchymal stem cell (MSC) therapy, Descartes-30, in patients with moderate-to-severe acute respiratory distress syndrome (ARDS), including that caused by COVID-19 -
Aurobindo Pharma net surges 39.5 per cent to Rs 636 crore
August 09, 2019Revenues stood at Rs 5,444.6 crore against Rs 4,250.3 crore and witnessed a strong growth of 28.1 per cent
Pharma Sources Insight January 2025
